When a doctor recommends cancer surgery, the conversation usually moves quickly. The diagnosis is fresh, the recommendations feel urgent, the family is processing news that takes weeks to fully absorb. In that compressed window, patients often consent to operations they haven’t fully understood.
This article is the conversation that should happen before consent. Eight questions you are entitled to ask. Eight answers that, taken together, tell you most of what you need to know about whether the recommended surgery is the right one, performed by the right team, in the right place, at the right cost.
1. “Is the surgeon being recommended a sub-speciality gynaecological oncologist?”
This is the most important question and the one most often unasked. The distinction between a general gynaecologist, a general surgical oncologist, and a sub-speciality gynaecological oncosurgeon is not cosmetic.
A gynaecological oncosurgeon has completed 2–3 years of fellowship training specifically in cancer surgery for women, on top of the basic gynaecology training. International evidence consistently shows that survival outcomes for ovarian cancer in particular are measurably better when surgery is performed by sub-speciality surgeons. The margin is meaningful.
If you are not sure of your surgeon’s specific training, ask directly. “Are you a fellowship-trained gynaecological oncologist, or a general gynaecologist or general surgical oncologist who performs cancer surgery?” The answer is informative either way.
2. “What is your annual case volume for cases like mine?”
Volume matters in cancer surgery. Surgeons who perform a given procedure more frequently produce better outcomes, across virtually every surgical procedure studied. For complex operations like cytoreductive surgery for advanced ovarian cancer or radical hysterectomy for cervical cancer, the volume-outcome relationship is particularly strong.
A reasonable threshold to ask about: how many of this specific procedure has the surgeon (or the team) performed in the last year? “Several” or “many” is not a real answer. Specific numbers are.
For very rare procedures (PIPAC, fertility-preserving radical trachelectomy), even a small annual volume can represent meaningful experience if the centre has accumulated cumulative cases over years. Ask about cumulative experience as well as recent volume.
3. “Has my case been discussed at a multidisciplinary tumour board?”
For any significant cancer treatment decision, a multidisciplinary tumour board, a formal meeting where multiple specialists jointly review the case, is the appropriate decision-making forum. Gynaecological oncologist, medical oncologist, radiation oncologist, pathologist, and radiologist should all be in the room (or in the discussion).
The reason this matters: cancer treatment decisions often have multiple valid paths, and the best path depends on integrating perspectives from different specialties. A surgical recommendation made by a surgeon alone, without medical-oncology and radiation-oncology input, misses information.
If your case has not yet been discussed at a tumour board and the case is significant (advanced stage, complex histology, unusual presentation), ask that it be. The delay is typically a few days. The added confidence is worth it.
4. “What are my alternative treatment options, and why is this approach being recommended over those?”
For most gynaecological cancers, multiple valid treatment approaches exist. For ovarian cancer, the major decisions include surgery first versus chemotherapy first, the addition of HIPEC, and the role of PARP inhibitor maintenance. For cervical cancer, the choices include surgical versus chemo-radiation approaches. For endometrial cancer, fertility-preserving hormonal management may be appropriate for selected young patients.
If your doctor presents a single recommended approach without discussing alternatives, you are missing decision-relevant information. Ask explicitly: “What other approaches are reasonable for my case, and why is the recommended one being preferred?”
A good answer references your specific stage, your histology, your overall fitness, and your personal preferences. A vague answer or a defensive one is a signal to get a second opinion.
5. “What is the realistic recovery trajectory?”
Recovery from gynaecological cancer surgery is not a single number. It is a trajectory across weeks and months that depends heavily on the specific operation, the post-operative protocol, and the patient’s baseline health.
Ask: – How long will I be in hospital? – How long until I can resume normal household activity? – How long until I can return to work? – What does the first 6 weeks look like in practical terms? – What is the typical complication rate, and what specifically should I watch for?
If your doctor’s answers are imprecise, you are probably underestimating the recovery. If the answers are realistic and specific, including honest acknowledgement of likely fatigue, return-to-baseline timeline, and possible complications, you can plan accordingly.
6. “What is the written cost estimate, including possible complications?”
Cost is medical information, not separate from it. Any reputable centre provides a written package estimate before consent. The estimate should include:
- Operating theatre and anaesthesia
- Hospital stay (ward and ICU)
- Standard medications
- Standard investigations during recovery
- The categories of cost that would trigger additional charges (complications, blood products beyond a routine allocation, extended ICU, etc.)
For complex operations like cytoreductive surgery with HIPEC, the realistic package range in major Indian tertiary centres is well-established. If the quote you receive is materially higher or lower than the typical range for your city, ask why.
Insurance pre-authorisation should be obtained before admission. The gap between insurer coverage and the package estimate is your realistic out-of-pocket cost. Knowing this before consent, not after surgery, is materially better for family planning.
7. “What happens if intra-operative findings differ from what we expect?”
Pre-operative imaging and biopsy provide a probabilistic understanding of what the surgeon will find at operation. The actual findings sometimes differ, more disease than expected, less disease than expected, a different histology than the biopsy suggested.
The right operating team has a plan for each possibility. Ask:
- What is the plan if the cancer is more advanced than imaging suggests?
- What is the plan if intra-operative frozen section reveals a different histology?
- Will the surgical team be authorised to convert to a more extensive operation if needed, or will the patient be brought back for a second operation?
- Will a sub-speciality gynaec oncologist be available intra-operatively if not already the primary surgeon?
The answers reveal how well the team is prepared for the realistic range of intra-operative scenarios. A team that has thought through these contingencies is a team you can trust with the decisions that may need to be made while you’re under anaesthesia.
8. “What is the post-treatment plan and surveillance schedule?”
Cancer treatment doesn’t end at surgery. The post-operative pathway includes adjuvant therapy (chemotherapy, radiation, hormonal therapy, PARP inhibitors), and then years of surveillance to detect recurrence early if it occurs.
A clear post-treatment plan answers:
- What adjuvant therapy is anticipated, and on what timeline?
- Where will the adjuvant therapy be administered?
- What is the surveillance schedule (visits, blood work, imaging)?
- Who is the long-term point of care, the surgical team, the medical oncology team, your local gynaecologist, or a combination?
- What is the expected timeline before you can return to normal life?
This is the conversation that often gets postponed until after surgery. It is materially more useful before surgery, because it sets realistic expectations and helps you plan for the months ahead.
The meta-question: is the conversation itself going well?
Beyond the eight specific questions, pay attention to how the surgeon answers them. A good clinical conversation has a few characteristic features:
- The surgeon takes the time to answer each question fully, without dismissiveness
- The answers reference your specific case, not generic information
- The surgeon acknowledges uncertainty where it exists rather than overclaiming
- The surgeon supports your right to seek a second opinion without taking offence
- The cost conversation is straightforward, not hedged
- The follow-up plan is concrete and specific
If the meta-conversation goes badly, defensive answers, vague reassurances, pressure to consent immediately, that is independent information about the team and the centre. Trust your reading of it.
Where to use this checklist
For most Indian families, the practical application is at the first specialist consultation after diagnosis. Bring this list. Work through it. If the answers are satisfactory, proceed with confidence. If they aren’t, request a second opinion from a gynaec oncologist before committing to a treatment plan.
The cost of asking these questions is twenty minutes. The cost of not asking is sometimes substantial. The arithmetic is straightforward.
About the author
This article was authored by Dr. Nishtha Tripathi Patel (MBBS, DGO, DNB, Fellowship in Gynaecological Oncology, ESGO-certified), an ESGO-certified gynaecological oncosurgeon in Ahmedabad. Reach the practice at +91 76988 00333.